Graziano, F <br/><br/>
Glycolysis gene expression analysis and selective metabolic advantage in the clinical progression of colorectal cancer.  [electronic resource] 

 -  The pharmacogenomics journal  06 2017 
 - 258-264 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1473-1150 
<br/><br/><label>Standard No.: </label>10.1038/tpj.2016.13  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Angiogenesis Inhibitors--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Biomarkers, Tumor--genetics<br/>Colectomy<br/>Colorectal Neoplasms--enzymology<br/>Disease Progression<br/>Drug Resistance, Neoplasm--genetics<br/>Female<br/>Gene Expression Profiling<br/>Gene Expression Regulation, Enzymologic<br/>Gene Expression Regulation, Neoplastic<br/>Genetic Predisposition to Disease<br/>Glycolysis--genetics<br/>Hepatectomy<br/>Humans<br/>Italy<br/>Kaplan-Meier Estimate<br/>Liver Neoplasms--enzymology<br/>Male<br/>Metastasectomy--methods<br/>Mutation<br/>Pharmacogenetics<br/>Pharmacogenomic Variants<br/>Phenotype<br/>RNA, Messenger--genetics<br/>Retrospective Studies<br/>Risk Factors<br/>Time Factors<br/>Treatment Outcome